Table 1 Demographic and clinical baseline data for the study patients (n = 252), according to physical and mental component summary-36 score quartiles
All patients | Physical component summary-36 score quartiles | Mental component summary-36 score quartiles | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Q1 Range: 9.6-30.0 | Q2 Range: 30.1-35.6 | Q3 Range: 35.7-44.4 | Q4 Range: 44.5–58.2 | P -value | Q1 Range: 16.9-39.2 | Q2 Range: 39.3-49.0 | Q3 Range: 49.1-55.6 | Q4 Range: 55.7-70.7 | P - value | ||
N | 252 | 63 | 63 | 63 | 63 | 63 | 63 | 63 | 63 | ||
Age, yrs, (252) | 60.2±15.5 | 60.8±12.4 | 64.8±14.9 | 58.1±17.3 | 57.2±16.0 | 0.027p | 56.5±15.7 | 63.7±15.3 | 60.0±17.0 | 60.6±13.0 | 0.071p |
Male gender,%, (n=252) | 65.9 (166) | 58.7 (37) | 68.3 (43) | 69.8 (44) | 66.7 (42) | 0.5632 | 61.9 (39) | 68.3 (43) | 77.8 (49) | 55.6 (35) | 0.0562 |
Current smoker, %, (n=252) | 25.8 (65) | 33.3 (21) | 23.8 (15) | 22.2 (14) | 23.8 (15) | 0.466 2 | 39.7 (25) | 22.2 (14) | 19.0 (12) | 22.2 (14) | 0.0342 |
Work status, %, (n) | |||||||||||
Able to work, (n=235) | 12.3 (29) | 8.5 (5) | 5.2 (3) | 12.1 (7) | 23.3 ( 14) | 0.016 2 | 6.7 (4) | 15.3 (9) | 12.7 (7) | 14.8 (9) | 0.4602 |
Disable to work, (n=235) | 51.5 (121) | 64.4 (38) | 43.1 (25) | 50.0 (29) | 48.3 (29) | 0.118 2 | 65.0 (39) | 35.6 (21) | 47.3 (26) | 57.4 (35) | 0.0092 |
Retired, (n=235) | 36.2 (85) | 27.1 (16) | 51.7 (30) | 37.9 (22) | 28.3 (17) | 0.02 2 | 28.3 (17) | 49.2 (29) | 40.0 (22) | 27.9 (17) | 0.0452 |
Cause of renal failure, %, (n) | |||||||||||
Glomerulonephritis, (n=249) | 20.5 (51) | 14.3 (9) | 20.6 (13) | 19.4 (12) | 27.9 (17) | 0.311 2 | 20.6 (13) | 12.7 (8) | 26.7 (16) | 22.2 (14) | 0.2762 |
Diabetic nephropathy, (n=249) | 14.1 (35) | 22.2 (14) | 6.3 (4) | 16.1 (10) | 11.5 (7) | 0.068 2 | 15.9 (10) | 14.3 (9) | 16.7 (10) | 9.5 (6) | 0.6632 |
Hypertensive kidney disease, (n=249) | 24.9 (62) | 25.4 (16) | 25.4 (16) | 27.4 (17) | 21.3 (13) | 0.886 2 | 25.4 (16) | 25.4 (16) | 23.3 (14) | 25.4 (16) | 0.9912 |
Other, (n=249) | 40.6 (101) | 38.1 (24) | 47.6 (30) | 37.1 (23) | 39.3 (24) | 0.613 2 | 38.1 (24) | 47.6 (30) | 33.3 (20) | 42.9 (27) | 0.4082 |
Clinical variables | |||||||||||
Dialysis vintage, mo, (n=251) | 9.0 (5.0, 23.0) | 18.0 (6.0, 34.0) | 9.0 (4.0, 20.0) | 9.0 (5.0, 20.0) | 7.0 (3.4, 16.8) | 0.004np | 10.0 (4.0, 23.0) | 11.0 (5.0, 32.0) | 10.0 (5.0, 17.3) | 7.0 (4.0, 24.0) | 0.352np |
Previous graft failure, (251) | 18.7 (47) | 24.2 (15) | 11.1 (7) | 19.0 (12) | 20.6 (13) | 0.287 2 | 22.2 (14) | 17.5 (11) | 21.0 (13) | 14.3 (9) | 0.6612 |
Accepted for renal transplantation, (n=252) | 38.1 (96) | 28.6 (18) | 27.0 (17) | 49.2 (31) | 47.6 (30) | 0.012 | 36.5 (23) | 33.3 (21) | 42.9 (27) | 39.7 (25) | 0.7182 |
Peritoneal dialysis, (n=252) | 20.2 (51) | 23.8 (15) | 14.3 (9) | 27.0 (17) | 15.9 (10) | 0.221 2 | 14.3 (9) | 19.0 (12) | 31.7 (20) | 15.9 (10) | 0.0622 |
Body mass index, kg/m2, (n=235) | 24.9±4.9 | 23.6±5.0 | 25.5±4.8 | 24.9±4.6 | 25.5±5.0 | 0.135p | 23.7±4.5 | 25.2±4.4 | 25.0±4.6 | 25.9±5.8 | 0.124p |
Serum albumin, g/l, (n=246) | 38.0±4.8 | 36.6±5.9 | 37.7±4.4 | 38.4±4.3 | 39.1±4.0 | 0.022p | 38.7±3.9 | 37.8±4.4 | 38.1±5.5 | 37.4±5.2 | 0.503p |
Hemoglobin, g/dl, (n=246) | 12.1±1.5 | 12.0±1.4 | 12.1±1.5 | 12.2±1.5 | 12.2±1.4 | 0.87p | 11.8±1.6 | 12.1±1.3 | 12.4±1.5 | 12.2±1.3 | 0.139p |
Total cholesterol, mmol/L, (n=230) | 4.2±1.1 | 4.0±1.2 | 4.1±1.1 | 4.5±1.1 | 4.2±1.1 | 0.103p | 4.3±1.2 | 4.0±1.0 | 4.2±1.2 | 4.3±1.1 | 0.279p |
Comorbidity | |||||||||||
Diabetes, %, (n=250) | 26.4 (66) | 31.7 (20) | 28.6 (18) | 24.2 (15) | 21.0 (13) | 0.537 2 | 30.2 (19) | 33.3 (21) | 27.9 (17) | 14.3 (9) | 0.0772 |
CCI without age, (n=248) | 4 (2, 5) | 5 (4, 6) | 4 (2, 4) | 3 (2, 5) | 3 (2, 4) | <0.001np | 4 (3, 5) | 4 (3, 5) | 4 (2, 5) | 3 (2, 5) | 0.436np |